Treatment | Day of treatment or re-infestation | |||||||
---|---|---|---|---|---|---|---|---|
0 | 14 | 28 | 42 | 58 | 76 | 90 | ||
Placebo | Range | 19–31 | 3–18 | 8–21 | 7–37 | 10–32 | 6–26 | 8–21 |
A. mean | 24.6 | 10.8 | 13.1 | 17.4 | 19.8 | 14.9 | 16.5 | |
G. mean1 | 24.4a | 9.4a | 12.6a | 15.5a | 18.7a | 13.4a | 15.7a | |
Sarolaner | Range | 0–7 | 0–2 | 0–10 | 0–10 | 2–14 | 0–5 | 0–9 |
A. mean | 0.9 | 1.0 | 3.6 | 2.8 | 6.1 | 1.1 | 2.6 | |
Efficacy (%) | 96.4 | 90.7 | 72.4 | 84.2 | 69.0 | 92.4 | 84.1 | |
G. mean1 | 0.3b | 0.8b | 2.1b | 1.3b | 5.4b | 0.8b | 1.7b | |
Efficacy (%) | 98.8 | 91.6 | 83.1 | 91.6 | 71.3 | 94.3 | 89.4 | |
P-value vs placebo | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | |
Fluralaner | Range | 0–4 | 0–9 | 0–11 | 6–32 | 13–24 | 7–18 | 7–26 |
A. mean | 0.9 | 2.6 | 3.4 | 19.1 | 16.9 | 11.6 | 15.9 | |
Efficacy (%) | 96.4 | 75.6 | 74.3 | 0.0 | 14.6 | 21.8 | 3.8 | |
G. mean1 | 0.5b | 1.4b | 2.2b | 17.4a | 16.6a | 11.2a | 14.8a | |
Efficacy (%) | 97.8 | 85.2 | 82.4 | 0.0 | 11.5 | 16.8 | 5.8 | |
P-value vs placebo | < 0.0001 | < 0.0001 | < 0.0001 | 0.6487 | 0.6360 | 0.4870 | 0.8182 | |
P-value vs sarolaner | 0.5715 | 0.3246 | 0.9247 | < 0.0001 | 0.0006 | < 0.0001 | < 0.0001 |